Monostory K. Combined action of phenobarbital and dexamethasone on the activity liver P450 system. (1993) ACTA PHARMACEUTICA HUNGARICA 0001-6659 63 296-300,
112290
Osicka-Koprowska A et al. The effect of dexamethasone pretreatment on the level of diazepam and its major metabolites in rat plasma. (2001) Acta Poloniae Toxicologica 1230-6967 9 143-151
Osicka-Koprowska A et al. The effect of dexamethasone pretreatment on chlordiazepoxide and oxazepam levels in rat plasma.. (1999) Acta Poloniae Pharmaceutica - Drug Research 56 6 439-442
Takayanagui OM. Therapy for neurocysticercosis: pharmacokinetic interaction of albendazole sulfoxide with dexamethasone.. (1997) Ther. Drug Monit. 19 51-55
Monostory K et al. The effect of phenobarbital and dexamethasone coadministration on the activity of rat liver P450 system. (1994) BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 0006-291X 1090-2104 203 351-358,
112344
Bizerra P.F.V. et al. Enhanced cytotoxicity of imidacloprid by biotransformation in isolated hepatocytes and perfused rat liver. (2020) PESTICIDE BIOCHEMISTRY AND PHYSIOLOGY 0048-3575 1095-9939 164 183-190
Hassan Hozeifa M et al. Dexamethasone Pretreatment Alleviates Isoniazid/Lipopolysaccharide Hepatotoxicity: Inhibition of Inflammatory and Oxidative Stress. (2017) FRONTIERS IN PHARMACOLOGY 1663-9812 8
Sanchez S et al. Dexamethasone decreases plasma levels of the prochiral fenbendazole and its chiral and achiral metabolites in sheep. (2003) XENOBIOTICA: THE FATE OF FOREIGN COMPOUNDS IN BIOLOGICAL SYSTEMS 0049-8254 1366-5928 33 7 731-742
Morfin R. Involvement of steroids and cytochromes P-450 species in the triggering of immune defenses. (2002) JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY 0960-0760 1879-1220 80 3 273-290
Hadasova E et al. Influence of pretreatment with immunosuppressants on O-demethylation of dextromethorphan in isolated perfused rat liver. (1999) EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY 0940-2993 51 4-5 330-334
Morel G et al. Evaluation of rat hepatic 2E1 activity in function of age, sex and inducers: choice of an experimental model capable of testing the hepatotoxicity of low molecular weight compounds. (1999) TOXICOLOGY LETTERS 0378-4274 1879-3169 106 2-3 171-180
Zerilli A et al. Effect of pyrazole and dexamethasone administration on cytochrome P450 2E1 and 3A isoforms in rat liver and kidney: Lack of specificity of p-nitrophenol as a substrate of P450 2E1. (1998) ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH 0145-6008 1530-0277 22 3 652-657
Bastien MC et al. Characterization of cytochrome P450 2E1 activity by the [14C]nitrosodimethylamine breath test.. (1998) CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY 0008-4212 1205-7541 76 756-763
Attal-Khémis S et al. Change of 7α-hydroxy-dehydroepiandrosterone levels in serum of mice treated by cytochrome P450-modifying agents. (1998) LIFE SCIENCES 0024-3205 63 17 1543-1553
Zhao XJ et al. The in vitro hepatic metabolism of quinine in mice, rats and dogs: Comparison with human liver microsomes. (1997) JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS 0022-3565 1521-0103 283 3 1168-1176
Nebbia C et al. Gender differences in ethanol oxidation and cytochrome P4502E1 content and functions in hepatic microsomes from alcohol-preferring and non-preferring rats. (1996) XENOBIOTICA: THE FATE OF FOREIGN COMPOUNDS IN BIOLOGICAL SYSTEMS 0049-8254 1366-5928 26 11 1121-1129
Monostory K et al. Interaction of theophylline and ipriflavone at the cytochrome P450 level. (1995) EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS 0378-7966 20 43-47,
112388
Mohos Violetta et al. Interactions of casticin, ipriflavone, and resveratrol with serum albumin and their inhibitory effects on CYP2C9 and CYP3A4 enzymes. (2018) BIOMEDICINE & PHARMACOTHERAPY 0753-3322 1950-6007 107 777-784
Wang C.-S. et al. Effects of Dendrobium huoshanense on expressions and activities of hepatic microsomal cytochrome P450s in mice. (2018) ZHONGGUO ZHONGYAO ZAZHI - CHINA JOURNAL OF CHINESE MATERIA MEDICA 1001-5302 43 21 4323-4329
Moon Y et al. Characterization of cytochrome P450s mediating ipriflavone metabolism in human liver microsomes. (2007) XENOBIOTICA: THE FATE OF FOREIGN COMPOUNDS IN BIOLOGICAL SYSTEMS 0049-8254 1366-5928 37 3 246-259
DerMarderosian A et al. Supplements and Herbs. (2006) Megjelent: Complementary and Alternative Medicine for Older Adults A Guide to Holistic Approaches to Healthy Aging pp. 31-78
Nadai M et al. Time-dependent effects of Klebsiella pneumoniae endotoxin on hepatic drug-metabolizing enzyme activity in rats. (1998) JOURNAL OF PHARMACY AND PHARMACOLOGY 0022-3573 2042-7158 50 8 871-879
Xu X et al. Effects of soy isoflavones on estrogen and phytoestrogen metabolism in premenopausal women. (1998) CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION 1055-9965 1538-7755 7 12 1101-1108
Rohatagi S et al. Pharmacokinetics of ipriflavone and metabolites after oral administration of a corn-oil suspension relative to the Osteofix tablet.. (1997) AMERICAN JOURNAL OF THERAPEUTICS 1075-2765 4 229-238
Rohatagi S et al. Integrated pharmacokinetic and metabolic modeling of ipriflavone and metabolites after oral administration.. (1997) AMERICAN JOURNAL OF THERAPEUTICS 1075-2765 4 189-198
Monostory K et al. The effect of ipriflavone and its main metabolites on thophyline biotransformation. (1996) EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS 0378-7966 21 61-66,
112437
Delarmelina JM et al. Antimutagenic activity of ipriflavone against the DNA-damage induced by cyclophosphamide in mice. (2014) FOOD AND CHEMICAL TOXICOLOGY 0278-6915 65 140-146
Moon Y et al. Characterization of cytochrome P450s mediating ipriflavone metabolism in human liver microsomes. (2007) XENOBIOTICA: THE FATE OF FOREIGN COMPOUNDS IN BIOLOGICAL SYSTEMS 0049-8254 1366-5928 37 3 246-259
DerMarderosian A et al. Supplements and Herbs. (2006) Megjelent: Complementary and Alternative Medicine for Older Adults A Guide to Holistic Approaches to Healthy Aging pp. 31-78
Yao Tong et al. Determination of ipriflavone metabolism in rat hepatic microsomes by RP-HPLC. (2003) The Chinese Journal of Modern applied Pharmacy 20 444-449
Wassenaar P.N.H. et al. Variability in fish bioconcentration factors: Influences of study design and consequences for regulation. (2020) CHEMOSPHERE 0045-6535 239
Dong H. et al. Responses of antioxidant and biotransformation enzymes in Carassius carassius exposed to hexabromocyclododecane. (2018) ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY 1382-6689 62 46-53
Olufsen M et al. Endocrine, biotransformation, and oxidative stress responses in salmon hepatocytes exposed to chemically induced hypoxia and perfluorooctane sulfonamide (PFOSA), given singly or in combination. (2015) ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH 0944-1344 1614-7499 22 17350-17366
El-kadi MAH et al. Molecular characterization and organs expression of cytochrome P450 1B1 from Japanese eel (Anguilla japonica). (2014) Egyptian Journal of Aquatic Biology and Fisheries 2536-9814 18 2 103-113
Cárcamo JG et al. Emamectin benzoate treatment alters the expression and activity of CYP1A, FMO and GST in different tissues of rainbow trout (Oncorhynchus mykiss). (2014) AQUACULTURE 0044-8486 434 188-200
Emborski C et al. Effect of β-naphthoflavone on hepatic cytochrome P4501A activity in the scribbled rabbitfish (Siganus spinus) from tropical Indo-Pacific coral reefs. (2012) ECOTOXICOLOGY 0963-9292 21 8 2153-2162
Kim JH et al. Molecular cloning and beta-naphthoflavone-induced expression of a cytochrome P450 1A (CYP1A) gene from an anadromous river pufferfish, Takifugu obscurus.. (2008) MARINE POLLUTION BULLETIN 0025-326X 57 433-440
Kim JH et al. cDNA cloning and expression of a xenobiotic metabolizing cytochrome P4501A (CYP1A) from the yellow catfish, Pelteobagrus fulvidraco (Siluriformes).. (2008) ENVIRONMENTAL TOXICOLOGY 1520-4081 1522-7278 23 3 346-353
Kaminishi Y. Complementary DNA cloning and organ expression of cytochrome P450 1C2 in carp (Cyprinus carpio).. (2007) ENVIRONMENTAL SCIENCES - TOKYO 0915-955X 14 1 23-33
Tagliari KC et al. Oxidative stress damage in the liver of fish and rats receiving an intraperitoneal injection of hexavalent chromium as evaluated by chemiluminescence. (2004) ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY 1382-6689 17 149-157
Koponen K et al. Intrastrain and interastin variability in biotransformation enzyme activities of rainbow trout (Oncorhynchus mykiss). (1997) CANADIAN JOURNAL OF FISHERIES AND AQUATIC SCIENCES 0706-652X 1205-7533 54 2901-2906,
112493
Saunders L.J. et al. In vitro-in vivo extrapolation of hepatic and gastrointestinal biotransformation rates of hydrophobic chemicals in rainbow trout. (2020) AQUATIC TOXICOLOGY 0166-445X 1879-1514 228
Laue H. et al. Examining Uncertainty in in Vitro-In Vivo Extrapolation Applied in Fish Bioconcentration Models. (2020) ENVIRONMENTAL SCIENCE & TECHNOLOGY 0013-936X 1520-5851 54 15 9483-9494
Laue H et al. Predicting the bioconcentration of fragrance ingredients by rainbow trout using measured rates of in vitro intrinsic clearance. (2014) ENVIRONMENTAL SCIENCE & TECHNOLOGY 0013-936X 1520-5851 48 16 9486-9495
Page GI et al. Astaxanthin and canthaxanthin do not induce liver or kidney xenobiotic-metabolizing enzymes in rainbow trout (Oncorhynchus mykiss Walbaum). (2002) COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-TOXICOLOGY AND PHARMACOLOGY 1532-0456 1878-1969 1878-1659 133 3 443-451
Bello SM et al. Acquired resistance to Ah receptor agonists in a population of Atlantic killifish (Fundulus heteroclitus) inhabiting a marine superfund site: In vivo and in vitro studies on the inducibility of xenobiotic metabolizing enzymes. (2001) TOXICOLOGICAL SCIENCES 1096-6080 1096-0929 60 1 77-91
Ludányi K et al. Application of TLC-FAB mass spectrometry in metabolism research. (1997) JPC - JOURNAL OF PLANAR CHROMATOGRAPHY - MODERN TLC 0933-4173 1789-0993 10 2 90-96,
1214669
Bhatt N.M. et al. Densitometry and indirect normal-phase HPTLC–ESI–MS for separation and quantitation of drugs and their glucuronide metabolites from plasma. (2019) BIOMEDICAL CHROMATOGRAPHY 0269-3879 1099-0801 33 10
Dzido Tadeusz H et al. Pressurized planar electrochromatography as a supporting tool for qualitative toxicological chemical analysis with thin-layer chromatography and UV-Vis spectrometry. (2017) JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES 1082-6076 1520-572X 40 5-6 320-326
Glazkov IN et al. Determination of Organic Impurities in Pharmaceutical Preparations: Определение органических примесей в фармацевтических препаратах. (2005) Zhurnal Analiticheskoj Khimii 0044-4502 60 2 124-136
Nasal A et al. Chromatographic retention parameters in medicinal chemistry and molecular pharmacology. (2003) CURRENT MEDICINAL CHEMISTRY 0929-8673 1875-533X 10 5 381-426
John Bladek. Application of Thin- Layer chromatorgaphy in clinical chemistry. (2003) Megjelent: Separation techniques in clinical chemistry pp. 433-489
Forgács E et al. Thin-layer chromatography of natural pigments: new advances. (2002) JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES 1082-6076 1520-572X 25 10-11 1521-1541
Kalasz H et al. Pharmaceutical applications of thin-layer chromatography. (2002) LC GC NORTH AMERICA: SOLUTION FOR SEPARATION SCIENTISTS 1527-5949 1939-1889 2002 Suppl. S 53-60
Cserhati T et al. TLC-FTIR of color pigments of chestnut sawdust. (2001) JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES 1082-6076 1520-572X 24 10 1435-1445
Prosek M et al. Quantification of caffeine by off-line TLC-MS. (2000) JPC - JOURNAL OF PLANAR CHROMATOGRAPHY - MODERN TLC 0933-4173 1789-0993 13 452-456
Chang Y et al. New techniques of tandem mass spectrometry and its application in the study of drug metabolism. (2000) ACTA PHARMACEUTICA SINICA 0513-4870 35 1 73-78
Kalász H et al. Chapter 10 Basis and pharmaceutical applications of thin-layer chromatography. (2000) Megjelent: Separation Methods in Drug Synthesis and Purification pp. 439-501
Brzezinka H et al. Thin-layer chromatography and mass spectrometry for screening of biological samples for drugs and metabolites. (1999) JPC - JOURNAL OF PLANAR CHROMATOGRAPHY - MODERN TLC 0933-4173 1789-0993 12 96-108
Wilson ID. The state of the art in thin-layer chromatography-mass spectrometry: a critical appraisal. (1999) JOURNAL OF CHROMATOGRAPHY A 0021-9673 1873-3778 856 429-442
Litvinova LS et al. Separation of C60 and C70 fullerenes by thin-layer chromatography on silica gel impregnated with polymers. (1999) JOURNAL OF AOAC INTERNATIONAL 1060-3271 82 2 227-238
Vingler P et al. Low-level radioquantitation of lipids and steroids in the pilosebaceous gland - A journey to the limit of a sparkling chamber. (1999) JPC - JOURNAL OF PLANAR CHROMATOGRAPHY - MODERN TLC 0933-4173 1789-0993 12 244-254
Anderson RM et al. Thin-layer chromatography coupled with mass spectrometry: Interfaces to electrospray ionization. (1998) JPC - JOURNAL OF PLANAR CHROMATOGRAPHY - MODERN TLC 0933-4173 1789-0993 11 336-341
Monostory K et al. Species differences in metabolism of panomifene, an analogue of tamoxifen. (1997) DRUG METABOLISM AND DISPOSITION 0090-9556 1521-009X 25 1370-1378,
112488
Tandon N. et al. Recent Advances in the Synthesis of Tamoxifen and Analogues in Medicinal Chemistry. (2020) ASIAN JOURNAL OF ORGANIC CHEMISTRY 2193-5807 2193-5815 9 10 1432-1465
Barthelemy A.-L. et al. Photoredox-Catalyzed Selective Synthesis of Allylic Perfluoroalkanes from Alkenes. (2020) CHEMISTRY-A EUROPEAN JOURNAL 0947-6539 1521-3765
Mazeh S. et al. Advances in the Synthesis of Fluorinated Scaffolds by Transition Metal-Catalyzed C-H Bond Activation. (2020) CHIMIA 0009-4293 74 11 871-877
Shagufta et al. Tamoxifen a pioneering drug: An update on the therapeutic potential of tamoxifen derivatives. (2018) EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY 0223-5234 1768-3254 143 515-531
Yamamoto Y et al. Selective synthesis of trisubstituted (trifluoromethyl) alkenes via ligand-free Cu-catalyzed syn hydroarylation, hydroalkenylation and hydroallylation of (trifluoromethyl) alkynes. (2016) GREEN CHEMISTRY 1463-9262 1463-9270 18 17 4628-4632
Ma J.-J. et al. Decarboxylative and Denitrative Trifluoromethylation for the Synthesis of Cvinyl-CF3 Compounds with Togni (II) Reagent. (2015) ADVANCED SYNTHESIS & CATALYSIS 1615-4150 1615-4169 357 16-17 3447-3452
Shimizu M et al. New preparation and synthetic reactions of 3,3,3-trifluoropropynyllithium, -borate and -stannane: facile synthesis of trifluoromethylated allenes, arylacetylenes and enynes. (2009) FUTURE MEDICINAL CHEMISTRY 1756-8919 1756-8927 1 5 921-945
Meegan Mary et al. Understanding the Molecular Mechanism of Action of Estrogen Receptor Modulators. (2005) FRONTIERS IN MEDICINAL CHEMISTRY 1567-2042 1875-5763 2 1 183-231